BERKELEY, Calif., Feb. 15, 2024 -- Caribou Biosciences, Inc. , a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced the company’s participation in the...

Related Keywords

Berkeley , California , United States , Peggy Vorwald , Samy Figueroa , Caribou Biosciences Inc , Nasdaq , Globenewswire Inc , Oncology Leadership , Markets ,